Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01666106 · ClinicalTrials.gov registry record
Osteonecrosis of the Jaw (ONJ) Case Registry
A clinical trial of Osteonecrosis of the Jaw, sponsored by Amgen.
- Completed
- Registry status
- 327
- Enrollment target
- 20
- Study locations
NCT01666106: Completed study of Osteonecrosis of the Jaw, sponsored by Amgen.
NCT01666106 is a study of Osteonecrosis of the Jaw that has completed, run by Amgen. The registered enrollment target is 327 participants. The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01666106, a study of Osteonecrosis of the Jaw, has completed, sponsored by Amgen.
- COMPLETED
- Registry status
- 327 participants
- Enrollment target
- 20
- Study locations
Study Summary
Osteonecrosis of the Jaw (ONJ) Case Registry
Primary Outcome
* Resolution: complete coverage of the exposed bone by mucosa in the absence of clinical symptoms * Improvement: a decrease in the stage or severity of the lesion * Progression: an increase in the stage or severity of the lesion * Stable: not resolved, improved, or progressed
Conditions Studied
Study Locations (20)
New York
- Research Site - Buffalo
- Research Site - Buffalo
- Research Site - Mineola
California
- Research Site - Beverly Hills
- Research Site - Duarte
Connecticut
- Research Site - Farmington
- Research Site - Stratford
Nebraska
- Research Site - Omaha
- Research Site - Omaha
Colorado
- Research Site - Denver
District of Columbia
- Research Site - Washington D.C.
Florida
- Research Site - Gainesville
Georgia
- Research Site - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 327 participants |
| Start Date | 2012-10-01 |
| Est. Completion | 2020-12-16 |
What the finished NCT01666106 record still lists
NCT01666106 is an observational study that tracks outcomes without assigning an intervention. The registered 327 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Osteonecrosis of the Jaw appearing as the primary indexed condition, and to 0 interventions.
NCT01666106 names 20 study sites across 15 states, led by New York, California, Connecticut.
Frequently Asked Questions
What is clinical trial NCT01666106 about?
NCT01666106 is a clinical study titled "Osteonecrosis of the Jaw (ONJ) Case Registry". Osteonecrosis of the Jaw (ONJ) Case Registry
What is the current status of trial NCT01666106?
This trial is currently completed. The enrollment target is 327 participants. The study started on 2012-10-01. Estimated completion is 2020-12-16.
What conditions does trial NCT01666106 study?
This clinical trial studies the following conditions: Osteonecrosis of the Jaw.
Who is sponsoring clinical trial NCT01666106?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01666106 being conducted?
This trial has 20 study locations across California, Colorado, Connecticut, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteonecrosis of the Jaw
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486378 · 327 participants · Phase 2
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
- NCT06370182 · 327 participants · NA
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
- NCT05156983 · 328 participants · Phase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
- NCT05380401 · 328 participants · NA
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI